S1 Biopharma
Manufacturing · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
250 Greenwich St Fl 467, New York, New Y...Phone Number
(201) 839-0941Website
www.s1biopharma.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About S1 Biopharma
S1 Biopharma, Inc. is a clinical-stage biopharmaceutical company developing treatments for sexual dysfunction in both women and men. The company was founded in 2008 and is headquartered in New York City, New York.Explore more
S1 Biopharma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is S1 Biopharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once S1 Biopharma has new funding data
Check out if S1 Biopharma is spiking on competitors!
Product Launch: Get notified when S1 Biopharma launches new products
Earning: See what the market has to say on S1 Biopharma recently announced quarterly report
Check if S1 Biopharma has recently received funding, and reach out quickly before it becomes old news!
Click to see if S1 Biopharma had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at S1 Biopharma
S1 Biopharma, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at S1 Biopharma
Find 2 more new buyers
Compare Similar Companies to S1 Biopharma
Compare insights from companies similar to S1 Biopharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
S1 Biopharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
S1 Biopharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about S1 Biopharma.
S1 Biopharma Tech Stack
A closer look at the technologies used by S1 Biopharma
See more technologies
S1 Biopharma News & Media
US Capital Global Securities Launches $15 Million Equity Investment in Clinical Stage Pharmaceutical Company
San Francisco-based private financial group engaged by pharmaceutical company as lead placement agent for capital raise. (PRWeb April 08, 2019) Read the full story at https://www.prweb.com/releases/us_capital_global_securities_launches_15_million_equity_investment_in_clinical_stage_pharmaceutical_company/prweb16226087.htmS1 Biopharma Announces Expanded Analysis of Phase 2a Data on Lorexys™ for Treatment of Hypoactive Sexual Desire Disorder Based on PGIC Scale to be Presented at 2019 ISSWSH/ISSM Joint Meeting
NEW YORK, Jan. 4, 2019 /PRNewswire/ -- S1 Biopharma, Inc. (S1) announced today that researchers will present an expanded analysis of data from the company's Phase 2a clinical trial of Lorexys™ for the treatment of women with hypoactive sexual desire disorder (HSDD) based on the Patient...S1 Biopharma to Participate in Panel Discussion on Investment Opportunities in China Hosted by Duane Morris and the Chinese Biopharmaceutical Association
NEW YORK, Jan. 4, 2019 /PRNewswire/ -- S1 Biopharma, Inc. (S1) announced today that the company will participate in a panel discussion, "Innovation Across Borders: Strategies for U.S. and Chinese Companies in the Health Sciences Industry," to be hosted by Duane Morris LLP and the Chinese...S1 Biopharma Granted Patents for Lorexys™ in Europe and Asia for Treatment of Hypoactive Sexual Desire Disorder
NEW YORK, Dec. 20, 2018 /PRNewswire/ -- S1 Biopharma, Inc. (S1) announced today that the European Patent Office has granted a European Patent for the Company's proprietary dual-mechanistic therapy Lorexys™ for hypoactive sexual desire disorder. A corresponding patent was previously...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding S1 Biopharma
Sign Up For FreeTo access detailed company insights
S1 Biopharma, Inc. is a clinical-stage biopharmaceutical company developing treatments for sexual dysfunction in both women and men. The company was founded in 2008 and is headquartered in New York City, New York.... Read More
